Filing Details
- Accession Number:
- 0001127602-21-028723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-09 16:59:19
- Reporting Period:
- 2021-11-05
- Accepted Time:
- 2021-11-09 16:59:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649245 | G. Phillip Febbo | 5200 Illumina Way San Diego CA 92122 | Svp Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-11-05 | 446 | $408.14 | 4,015 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-11-08 | 1,000 | $406.83 | 3,015 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.